Suchergebnisse
Filter
13 Ergebnisse
Sortierung:
Regulating international business through codes of conduct
In: AEI-studies 287
In: Studies in Legal Policy, American Enterprise Institute for Public Policy Research
Implausible Results or Implausible Data? Anomalies in the Construction of Value-Added Data and Implications for Estimates of Price-Cost Markups
In: Journal of political economy, Band 99, Heft 6, S. 1315-1328
ISSN: 1537-534X
Implausible Results or Implausible Data? Anomalies in the Construction of Value-Added Data and Implications for Estimates of Price-Cost Markups
In: Journal of political economy, Band 99, Heft 6, S. 1315
ISSN: 0022-3808
The Domestic Council: Innovation in Presidential Government
In: Public administration review: PAR, Band 36, Heft 3, S. 260
ISSN: 1540-6210
International aviation: the fuel crisis and other problems [based on address]
In: The Department of State bulletin: the official weekly record of United States Foreign Policy, Band 70, S. 192-197
ISSN: 0041-7610
The changing outlook for U.S. aerospace abroad: a State department perspective [on trade possibilities for aerospace products; address]
In: The Department of State bulletin: the official weekly record of United States Foreign Policy, Band 70, S. 588-592
ISSN: 0041-7610
Managed Trade: The New Competition between Nations
In: Foreign affairs: an American quarterly review, Band 65, Heft 4, S. 897
ISSN: 2327-7793
The Survival of Noise Traders in Financial Markets
In: The journal of business, Band 64, Heft 1, S. 1
ISSN: 1537-5374
Noise Trader Risk in Financial Markets
In: Journal of political economy, Band 98, Heft 4, S. 703-738
ISSN: 1537-534X
Noise Trader Risk in Financial Markets
In: Journal of political economy, Band 98, Heft 4, S. 703
ISSN: 0022-3808
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types.
BASE